Injective (INJ) Reclaims $14 Despite Regulatory Headwinds as Institutional Adoption Surges

INJ trades at $14.16 (+1.22%) showing resilience after Pineapple Financial’s $100M investment, while technical indicators suggest bullish momentum despite recent regulatory pressures. (Read More)

​